GRAIL/$GRAL
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About GRAIL
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Ticker
$GRAL
Sector
Primary listing
Employees
910
Headquarters
Website
GRAIL Metrics
BasicAdvanced
$2.6bn
-
-$10.31
-
-
Price and volume
Market cap
$2.6bn
52-week high
$118.84
52-week low
$29.95
Average daily volume
783k
Financial strength
Current ratio
11.744
Quick ratio
11.29
Long term debt to equity
1.643
Total debt to equity
2.041
Profitability
EBITDA (TTM)
-360.204
Gross margin (TTM)
49.28%
Net profit margin (TTM)
-253.22%
Operating margin (TTM)
-330.74%
Effective tax rate (TTM)
23.33%
Revenue per employee (TTM)
$170,000
Management effectiveness
Return on assets (TTM)
-11.42%
Return on equity (TTM)
-16.09%
Valuation
Price to revenue (TTM)
14.697
Price to book
0.98
Price to tangible book (TTM)
3.6
Price to free cash flow (TTM)
-7.849
Free cash flow yield (TTM)
-12.74%
Free cash flow per share (TTM)
-7.625
Growth
Revenue change (TTM)
19.44%
Earnings per share change (TTM)
-82.38%
What the Analysts think about GRAIL
Analyst ratings (Buy, Hold, Sell) for GRAIL stock.
GRAIL Financial Performance
Revenues and expenses
GRAIL Earnings Performance
Company profitability
GRAIL News
AllArticlesVideos
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL
Newsfile Corp·20 hours ago
GRAL INVESTOR DEADLINE: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Newsfile Corp·20 hours ago
GRAL UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026
Newsfile Corp·1 day ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs